ATE129013T1 - Steroid 5-alpha-reduktase. - Google Patents
Steroid 5-alpha-reduktase.Info
- Publication number
- ATE129013T1 ATE129013T1 AT91909339T AT91909339T ATE129013T1 AT E129013 T1 ATE129013 T1 AT E129013T1 AT 91909339 T AT91909339 T AT 91909339T AT 91909339 T AT91909339 T AT 91909339T AT E129013 T1 ATE129013 T1 AT E129013T1
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- steroid
- alpha
- disclosed
- sequences
- Prior art date
Links
- 108010029908 3-oxo-5-alpha-steroid 4-dehydrogenase Proteins 0.000 title abstract 3
- 102000001779 3-oxo-5-alpha-steroid 4-dehydrogenase Human genes 0.000 title abstract 3
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 101710169367 3-oxo-5-alpha-steroid 4-dehydrogenase 2 Proteins 0.000 abstract 1
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 201000004384 Alopecia Diseases 0.000 abstract 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
- 201000009273 Endometriosis Diseases 0.000 abstract 1
- 206010020112 Hirsutism Diseases 0.000 abstract 1
- 108010044467 Isoenzymes Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 206010068168 androgenetic alopecia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 230000009088 enzymatic function Effects 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 210000004392 genitalia Anatomy 0.000 abstract 1
- 238000009396 hybridization Methods 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 238000004634 pharmacological analysis method Methods 0.000 abstract 1
- 201000001514 prostate carcinoma Diseases 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 238000007423 screening assay Methods 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
- C12Y103/01—Oxidoreductases acting on the CH-CH group of donors (1.3) with NAD+ or NADP+ as acceptor (1.3.1)
- C12Y103/01022—3-Oxo-5alpha-steroid 4-dehydrogenase (NADP+) (1.3.1.22), i.e. cortisone alpha-reductase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51766190A | 1990-04-30 | 1990-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE129013T1 true ATE129013T1 (de) | 1995-10-15 |
Family
ID=24060703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91909339T ATE129013T1 (de) | 1990-04-30 | 1991-04-25 | Steroid 5-alpha-reduktase. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5422262A (de) |
| EP (1) | EP0528906B1 (de) |
| JP (1) | JP3294844B2 (de) |
| AT (1) | ATE129013T1 (de) |
| AU (1) | AU642501B2 (de) |
| CA (1) | CA2079454C (de) |
| DE (1) | DE69113795T2 (de) |
| WO (1) | WO1991017251A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU642501B2 (en) * | 1990-04-30 | 1993-10-21 | Board Of Regents, The University Of Texas System | Steroid 5alpha-reductases |
| US5576191A (en) * | 1994-06-17 | 1996-11-19 | Immunex Corporation | Cytokine that binds ST2 |
| US5656613A (en) * | 1995-01-04 | 1997-08-12 | Merck & Co., Inc. | Treatment of hyperandrogenic conditions |
| US20020170077A1 (en) * | 1995-02-10 | 2002-11-14 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| US6359194B1 (en) | 1995-02-10 | 2002-03-19 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| US5834248A (en) * | 1995-02-10 | 1998-11-10 | Millennium Pharmaceuticals Inc. | Compositions and methods using rchd534, a gene uregulated by shear stress |
| IT1276662B1 (it) * | 1995-04-04 | 1997-11-03 | Uni Degli Studi Camerino | Vaccini polinucleotidici |
| EP0866859A4 (de) * | 1995-12-07 | 2000-02-02 | Baylor College Medicine | Nukleotid- und aminosäuresequenzen des wachstumsfaktors aus dem sinus des urogenitaltraktes |
| EP0904277A4 (de) | 1996-02-16 | 2003-01-22 | Millennium Pharm Inc | Zusammensetzungen und verfahren zur behandlung und diagnose von kardiovaskulären krankheiten |
| AU2666797A (en) * | 1996-04-15 | 1997-11-07 | Dyad Pharmaceutical Corporation | Combination therapy for androgenic alopecia with antisense oligonucleotides and minoxidil |
| US6143950A (en) * | 1996-04-18 | 2000-11-07 | The Salk Institute For Biological Studies | Plant steroid 5α reductase, DET2 |
| DE69733947T2 (de) * | 1996-05-15 | 2006-06-14 | Altana Pharma Ag | Verfahren zur trennung und bestimmung von hydrophoben proteinen durch dünnschichtchromatographie |
| AU2238499A (en) | 1998-01-23 | 1999-08-09 | University Of Southern California | Androgen-metabolic gene mutations and prostate cancer risk |
| CA2330611A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
| EP1280915A1 (de) * | 2000-04-13 | 2003-02-05 | Millennium Pharmaceuticals, Inc. | Menschliche 5-alpha reductase und deren anwendungen |
| US6469150B1 (en) * | 2000-05-22 | 2002-10-22 | Pharmacopeia, Inc. | Cloning and characterization of genes encoding bradykinin B1 receptor homologues from five mammalian species |
| AU2002241768A1 (en) | 2000-10-30 | 2002-06-18 | Pharmacia Corporation | Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| NZ525726A (en) * | 2000-11-09 | 2004-10-29 | Astrazeneca Ab | Oral pharmaceutical composition containing a block copolymer |
| JP2002236307A (ja) * | 2001-02-09 | 2002-08-23 | Asahi Optical Co Ltd | ズームストロボ装置 |
| US7635598B2 (en) * | 2004-07-08 | 2009-12-22 | Biosearch Technologies, Inc. | Inducible fluorescence assay |
| US20070036740A1 (en) * | 2004-10-06 | 2007-02-15 | Reed Kenneth C | Modulation of hair growth |
| DK1889198T3 (da) | 2005-04-28 | 2015-02-09 | Proteus Digital Health Inc | Farma-informatiksystem |
| EP1945240B1 (de) | 2005-09-16 | 2016-12-28 | Raptor Pharmaceutical Inc | Zusammensetzungen mit rezeptor-assoziierten protein (rap) varianten, die für cr-haltige proteine spezifisch sind und ihre verwendungen |
| FR2903999B1 (fr) * | 2006-07-19 | 2008-09-05 | Galderma Res & Dev S N C Snc | Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee |
| ES2728225T3 (es) | 2009-02-20 | 2019-10-23 | 2 Bbb Medicines B V | Sistema de administración de fármacos a base de glutatión |
| CA2759098A1 (en) * | 2009-04-14 | 2010-10-21 | Smith Holdings, Llc | Methods and compositions for the treatment of medical conditions involving cellular programming |
| US8445002B2 (en) | 2009-05-06 | 2013-05-21 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| WO2021145458A1 (ja) * | 2020-01-16 | 2021-07-22 | 学校法人慶應義塾 | 胆汁酸を生成するための組成物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU642501B2 (en) * | 1990-04-30 | 1993-10-21 | Board Of Regents, The University Of Texas System | Steroid 5alpha-reductases |
-
1991
- 1991-04-25 AU AU78579/91A patent/AU642501B2/en not_active Ceased
- 1991-04-25 AT AT91909339T patent/ATE129013T1/de not_active IP Right Cessation
- 1991-04-25 EP EP91909339A patent/EP0528906B1/de not_active Expired - Lifetime
- 1991-04-25 JP JP50901491A patent/JP3294844B2/ja not_active Expired - Fee Related
- 1991-04-25 CA CA002079454A patent/CA2079454C/en not_active Expired - Fee Related
- 1991-04-25 WO PCT/US1991/002866 patent/WO1991017251A1/en active IP Right Grant
- 1991-04-25 DE DE69113795T patent/DE69113795T2/de not_active Expired - Fee Related
- 1991-11-18 US US07/795,859 patent/US5422262A/en not_active Expired - Lifetime
-
1995
- 1995-06-01 US US08/457,616 patent/US5679521A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0528906A1 (de) | 1993-03-03 |
| DE69113795T2 (de) | 1996-03-28 |
| EP0528906B1 (de) | 1995-10-11 |
| DE69113795D1 (de) | 1995-11-16 |
| AU642501B2 (en) | 1993-10-21 |
| JPH05507405A (ja) | 1993-10-28 |
| US5422262A (en) | 1995-06-06 |
| US5679521A (en) | 1997-10-21 |
| JP3294844B2 (ja) | 2002-06-24 |
| CA2079454C (en) | 2002-02-26 |
| WO1991017251A1 (en) | 1991-11-14 |
| CA2079454A1 (en) | 1991-10-31 |
| AU7857991A (en) | 1991-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE129013T1 (de) | Steroid 5-alpha-reduktase. | |
| Slominski et al. | Conversion of L‐tryptophan to serotonin and melatonin in human melanoma cells | |
| Normington et al. | Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions. | |
| DK1115874T3 (da) | Alzheimer's sygdom-sekretase | |
| DE69512219T2 (de) | Gezielte spaltung von rns mittels gezielter bindung der ribonuklease p und spaltungssequenzen | |
| TW200745552A (en) | HU-ASP 1 protease substrate and uses thereof | |
| DE69503129T2 (de) | Pteridin-nukleotidderivate als fluoreszierende sonden | |
| Champoux et al. | The effects of camptothecin on the reaction and the specificity of the wheat germ type I topoisomerase | |
| ATE309980T1 (de) | Zubereitungen zur verwendung als therapeutische und nachweismittel | |
| Wohl et al. | Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes. | |
| Tai et al. | Synthesis and evaluation of turn-on fluorescent probes for imaging steroid sulfatase activities in cells | |
| Riendeau et al. | Evidence for a fatty acid reductase catalyzing the synthesis of aldehydes for the bacterial bioluminescent reaction. Resolution from luciferase and dependence on fatty acids. | |
| Dizdaroglu et al. | A novel DNA N-glycosylase activity of E. coli T4 endonuclease V that excises 4, 6-diamino-5-formamidopyrimidine from DNA, a UV-radiation-and hydroxyl radical-induced product of adenine | |
| MXPA02010868A (es) | Secuencias de nucleotidos involucrados en el incremento o disminucion en la ovulacion mamifera. | |
| AU2002257284A1 (en) | Pna probes, probe sets, methods and kits pertaining to the detection of candida | |
| Katz et al. | Estradiol esters can replace 17β-estradiol in the stimulation of DNA and esterase synthesis by MCF-7 cells: a possible role for the estrogen-sensitive MCF-7 cell esterase | |
| Van Nest et al. | Effects of dexamethasone and 5-bromodeoxyuridine on protein synthesis and secretion during in vitro pancreatic development | |
| Todhunter et al. | Modification of rat liver RNA polymerase I after in vivo stimulation by hydrocortisone or methylisobutylxanthine | |
| US7501273B2 (en) | Peptidylarginine deiminase 6 | |
| Andersson et al. | Steroid 5A reductase nucleic acid segments and recombinant vectors and host cells | |
| AU2002304693A1 (en) | Peptidylarginine deiminase 6 | |
| Eichler et al. | Effect of human placental ribonuclease inhibitor in cell-free ribosomal RNA synthesis | |
| Berman | The roles of steroid 5-alpha reductase in the development of the male urogenital tract. | |
| MILLS et al. | New androgen-stimulated proteins in the kidneys of female mice | |
| Razzaboni et al. | Cyclic adenosine 3′, 5′-monophosphate-phosphodiesterases in epididymis and prostate of castrate and of aged rats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |